CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 8-K Event Other events
- 4 Option exercise Chief Accounting Officer acquired 21,030 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Shareholder vote results
- 4 Open-market buy Director bought 71,915 shares at an average $2.75 ($198,023)
- 4 Open-market buy Director bought 25,000 shares at an average $2.83 ($70,700)
- 4 Open-market buy Director bought 7,000 shares at $2.91 ($20,370)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 8-K Event Material agreement · New debt or obligation
Page 10 of 28 · 557 filings